Canada approves expensive new drug that can slow Alzheimer’s disease CTV NewsHealth Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease BiogenHealth Canada approves drug that slows progression of Alzheimer’s disease The Globe and MailHealth Canada Grants Authorization for LEQEMBI® (lecanemab) for the Treatment of Early Alzheimer’s Disease Newswire Canada
